FEBS Letters 1995-11-27

Agonist regulation of the expression of the delta opioid receptor in NG108-15 cells.

D S Kim, H Chin, W A Klee

Index: FEBS Lett. 376(1-2) , 11-4, (1995)

Full Text: HTML

Abstract

Exposure of neuronal cells to the chronic presence of opiates leads to a complex series of biochemical events which reflect the changes that result in tolerance and dependence in animals. To achieve a better understanding of the molecular mechanisms underlying these processes, we have examined the effect of agonist efficacy on the regulation of the delta-opioid receptor mRNA in NG108-15 cells. Incubation with various opiates decreased receptor numbers in the order of their efficacy. Northern blot analysis showed that there are 4 size classes of mRNA coding for the delta-opioid receptor in NG108-15 cells even though only one known protein species is found. Moreover, the amount of each transcript is coordinately decreased by long-term etorphine treatment, but not necessarily to the same extent. The etorphine-induced decrease in receptor mRNA was found to be slow in onset, whereas a much more rapid loss of receptor number was observed. This disparity suggests that the down-regulation induced by etorphine can occur both at the levels of receptor protein modification and receptor gene expression, and that the mechanisms of the two processes may be different.


Related Compounds

Related Articles:

Analysis of naltrexone and its metabolite 6-beta-naltrexol in serum with high-performance liquid chromatography.

2012-01-01

[BMC Res. Notes 5 , 439, (2012)]

GC-MS confirmation of codeine, morphine, 6-acetylmorphine, hydrocodone, hydromorphone, oxycodone, and oxymorphone in urine.

1999-01-01

[J. Anal. Toxicol. 23(3) , 177-86, (1999)]

Comparison of stably expressed rat UGT1.1 and UGT2B1 in the glucuronidation of opioid compounds.

1997-02-01

[Drug Metab. Dispos. 25(2) , 251-5, (1997)]

The mu opioid irreversible antagonist beta-funaltrexamine differentiates the discriminative stimulus effects of opioids with high and low efficacy at the mu opioid receptor.

1998-11-01

[Psychopharmacology 140 , 20, (1998)]

The glucuronidation of exogenous and endogenous compounds by stably expressed rat and human UDP-glucuronosyltransferase 1.1.

1996-08-01

[Arch. Biochem. Biophys. 332(1) , 92-100, (1996)]

More Articles...